纵横研报
Ticker Detail

600267.SHG

¥11.98+3.37% 海正药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Zhejiang Hisun Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.

MARKET 市值 13.40B CNY PE 18.9x Fwd 27.0x 52W ¥9.2 – ¥12.98 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 1.84 营收 YoY -9.2% ROE 7.9% 营业利润率 15.5% 净利润率 6.8%
ANALYST 股息率 1.95%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制